Published in Neurology on May 10, 2005
Age-varying association between statin use and incident Alzheimer's disease. J Am Geriatr Soc (2010) 2.34
Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag (2008) 2.13
Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch Arztebl Int (2011) 1.43
Association of statin use with cognitive decline in elderly African Americans. Neurology (2007) 1.34
Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis (2010) 1.22
Promoting successful cognitive aging: a comprehensive review. J Alzheimers Dis (2010) 1.19
Excessive sleepiness is predictive of cognitive decline in the elderly. Sleep (2012) 1.18
Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging. Neuroimage (2009) 1.17
Translational research in central nervous system drug discovery. NeuroRx (2005) 1.12
Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals. PLoS One (2012) 1.10
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol (2010) 1.08
Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Neurology (2006) 1.06
Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment. J Epidemiol Community Health (2010) 1.06
A prospective study of diurnal cortisol and cognitive function in community-dwelling elderly people. Psychol Med (2009) 1.04
Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study. Neurology (2009) 1.03
Increased atherogenic lipoproteins are associated with cognitive impairment: effects of statins and subclinical atherosclerosis. Alzheimer Dis Assoc Disord (2009) 1.02
Current therapeutic targets for the treatment of Alzheimer's disease. Expert Rev Neurother (2010) 0.99
Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics (2011) 0.97
Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults. Hum Brain Mapp (2012) 0.91
Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action. Pharmacol Res (2010) 0.90
Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents. Lipids Health Dis (2012) 0.89
Midlife predictors of Alzheimer's disease. Maturitas (2009) 0.89
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation. Neurobiol Dis (2013) 0.88
Use of statins and risk of hospitalization with dementia: a Danish population-based case-control study. Alzheimer Dis Assoc Disord (2009) 0.87
Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype. Curr Alzheimer Res (2011) 0.87
Statins, cognition, and dementia—systematic review and methodological commentary. Nat Rev Neurol (2015) 0.85
Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations. J Alzheimers Dis (2012) 0.85
Dyslipidemia and the risk of Alzheimer's disease. Curr Atheroscler Rep (2013) 0.85
Dementia syndromes: evaluation and treatment. Expert Rev Neurother (2007) 0.83
Molecular mechanisms underlying the effects of statins in the central nervous system. Int J Mol Sci (2014) 0.83
RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism. J Cell Mol Med (2009) 0.82
Prevention approaches in a preclinical canine model of Alzheimer's disease: benefits and challenges. Front Pharmacol (2014) 0.82
Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers. Alzheimer Dis Assoc Disord (2010) 0.81
Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis. PLoS Med (2014) 0.81
On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks. Alzheimer Dis Assoc Disord (2009) 0.81
Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors. Front Aging Neurosci (2014) 0.80
Neurovascular changes measured by time-of-flight MR angiography in cholesterol-fed rabbits with cortical amyloid beta-peptide accumulation. J Magn Reson Imaging (2010) 0.80
Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels. PLoS One (2011) 0.80
Apolipoprotein E is associated with blood lipids and inflammation in Taiwanese older adults. Atherosclerosis (2011) 0.78
A review of the potential therapeutic role of statins in the treatment of Alzheimer's disease: current research and opinion. Neuropsychiatr Dis Treat (2013) 0.78
Factors related to long-term post-stroke cognitive impairment in young adult ischemic stroke. Med Sci Monit (2015) 0.77
Vascular cognitive impairment. Indian J Psychiatry (2009) 0.77
Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial. Trials (2014) 0.77
Coenzyme Q10 and cognition in atorvastatin treated dogs. Neurosci Lett (2011) 0.76
β-sitosterol inhibits high cholesterol-induced platelet β-amyloid release. J Bioenerg Biomembr (2011) 0.76
Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans. Ethn Dis (2015) 0.76
Therapeutic interventions targeting Beta amyloid pathogenesis in an aging dog model. Curr Neuropharmacol (2011) 0.76
Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study. PLoS Med (2017) 0.75
Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial. Trials (2016) 0.75
Vascular cognitive impairment: Current concepts and Indian perspective. Ann Indian Acad Neurol (2010) 0.75
Is dementia preventable? Dialogues Clin Neurosci (2009) 0.75
Commentary on "the Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics". Alzheimers Dement (2008) 0.75
Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Dynamic strength of molecular adhesion bonds. Biophys J (1997) 14.93
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation (1994) 12.24
Energy landscapes of receptor-ligand bonds explored with dynamic force spectroscopy. Nature (1999) 10.45
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med (1994) 6.05
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Sensitive force technique to probe molecular adhesion and structural linkages at biological interfaces. Biophys J (1995) 5.45
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95
Strength of a weak bond connecting flexible polymer chains. Biophys J (1999) 3.88
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol (1991) 3.70
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology (2002) 3.57
Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J (2003) 3.55
Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc (1995) 3.51
Healthy life expectancy: evaluation of global indicator of change in population health. BMJ (1991) 3.45
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 3.14
Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet (2001) 2.70
Restriction in complex activities of daily living in MCI: impact on outcome. Neurology (2006) 2.64
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain (2006) 2.54
A 5-year longitudinal study of the Mini-Mental State Examination in normal aging. Am J Epidemiol (1997) 2.50
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry (1999) 2.33
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty. Circulation (2001) 2.26
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke (1991) 2.19
Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology (2001) 2.18
Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J (2004) 2.18
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Dietary patterns and risk of dementia: the Three-City cohort study. Neurology (2007) 2.09
The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J (2001) 2.08
Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet (1993) 2.06
A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM. Cephalalgia (1992) 2.05
The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol (1998) 2.04
Case-control study of migraine and risk of ischaemic stroke in young women. BMJ (1995) 2.03
Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol (1994) 1.96
Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet (1999) 1.95
Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol (1991) 1.89
Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care (2001) 1.88
Intake of flavonoids and risk of dementia. Eur J Epidemiol (2000) 1.85
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry (2012) 1.84
Breathing disorders during sleep and cognitive performance in an older community sample: the EVA Study. J Am Geriatr Soc (1996) 1.83
Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects. Neurology (2004) 1.82
Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.81
An ergonomic analysis of the fulcrum effect in the acquisition of endoscopic skills. Endoscopy (1998) 1.81
The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med (1992) 1.80
Low blood pressure and risk of depression in the elderly. A prospective community-based study. Br J Psychiatry (2000) 1.80
Migraine and risk of ischaemic stroke: a case-control study. BMJ (1993) 1.79
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) (1997) 1.77
Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr (1998) 1.74
Modelling age-specific risk: application to dementia. Stat Med (1998) 1.74
Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet (1999) 1.73
Prevalence of depressive symptoms and syndromes in later life in ten European countries: the SHARE study. Br J Psychiatry (2007) 1.72
Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry (2008) 1.71
Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology (2009) 1.70
Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology (1998) 1.68
Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology (1999) 1.67
Association of occurrence of aneurysmal bleeding with meteorologic variations in the north of France. Stroke (1994) 1.65
Variations in the APP gene promoter region and risk of Alzheimer disease. Neurology (2007) 1.64
Components of drinking water and risk of cognitive impairment in the elderly. Am J Epidemiol (1994) 1.64
Long-term prognosis in two forms of childhood epilepsy: typical absence seizures and epilepsy with rolandic (centrotemporal) EEG foci. Ann Neurol (1983) 1.64
Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol (2007) 1.60
Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet (1998) 1.60
Early epidural blood patch in spontaneous intracranial hypotension. Neurology (2004) 1.59
Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry (2011) 1.59
The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J (2002) 1.58
Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting. J Nutr Health Aging (2013) 1.57
Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology (2011) 1.57
Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry (2008) 1.56
Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract. J Urol (2008) 1.56
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation (1997) 1.55
Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke (1996) 1.54
Leisure-time physical activity and regular walking or cycling to work are associated with adiposity and 5 y weight gain in middle-aged men: the PRIME Study. Int J Obes Relat Metab Disord (2001) 1.53
Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet (1998) 1.53
Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation (2004) 1.52
Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc (1992) 1.52
Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation (2005) 1.52